1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France (2013). http://globocan.iarc.fr.
  Google Scholar
• 2 Díaz-Gavilán M, Gómez-Vidal JA, Choquesillo-Lazarte D et al. Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom. Tetrahedron 63(24), 5274–5286 (2007).
  CASGoogle Scholar
• 3 Conejo-García A, Gallo MA, Espinosa A, Campos JM. Latest advances on regioespecific microwave-assisted synthesis of novel purine derivatives as antitumour agents. Expert Opin. Ther. Pat. 12, 212–222 (2008).
  Google Scholar
• 4 Nunez MC, Diaz-Gavilan M, Conejo-Garcia A, Cruz-López O, Espinosa MA, Campos JM. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines. Curr. Med. Chem. 15(25), 2614–2631 (2008).
  Medline CASGoogle Scholar
• 5 López-Cara LC, Conejo-Garcia A, Marchal JA et al. New (RS)-benzoxazepin-purines with antitumor activity: the chiral switch from (RS)-2,6-Dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. Eur. J. Med. Chem. 46(1), 249–258 (2011). • Design, synthesized and antitumour effect of bozepinib.
  Medline CASGoogle Scholar
• 6 Marchal JA, Carrasco E, Ramírez A et al. Bozepinib, a novel small antitumour agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence. Drug Des. Devel. Ther. 7, 1301–1313 (2013).
  MedlineGoogle Scholar
• 7 Ramírez A, Boulaiz H, Morata-Tarifa C et al. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of bozepinib small compound. Oncotarget 5(11), 3590–3606 (2014). •• Establishes the mechanism of action by which bozepinib exerts its anticancer effect.
  MedlineGoogle Scholar
• 8 Conejo-García A, Núñez MC, Marchal JA et al. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines. Eur. J. Med. Chem. 43(8), 1742–1748 (2008). •• Evidences that the purine fragment does not exert an antiproliferative effect per se.
  Medline CASGoogle Scholar
• 9 Liu H, Li L, Qurat-ul-ain S, Jiang T. Synthesis and inhibitory activity evaluation of 2,6-disubstituted purine derivatives. J. Heterocyclic Chem. 52(2), 473–477 (2015).
  CASGoogle Scholar
• 10 Ningegowda R, Grover A, Basappa et al. Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivatives. Invest. New Drugs 28(6), 754–765 (2010). • Another research article regarding the modest antiproliferative effect of purine derivatives.
  Medline CASGoogle Scholar
• 11 Díaz-Gavilán M, Rodríguez-Serrano F, Gómez-Vidal JA et al. Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells. Tetrahedron 60(50), 11547–11557 (2004).
  CASGoogle Scholar
• 12 Macherey AC, Dansette PM. Biotransformations leading to toxic metabolites: chemical aspects. In: The Practice of Medicinal Chemistry (4th Edition). Wermuth CG (Ed.). Elsevier Ltd London, UK, Section V, 585–611 (2015).
  Google Scholar
• 13 Charafe-Jauffret E, Ginestier C, Iovino F et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin. Cancer Res. 16(1), 45–55 (2010).
  Medline CASGoogle Scholar
• 14 Jourdant A, González-Zamora E, Zhu J. Wilkinson's catalyst catalyzed selective hydrogenation of olefin in the presence of an aromatic nitro function: a remarkable solvent effect. J. Org. Chem. 67(9), 3163–3164 (2002). •• An interesting research article regarding the selective reduction of the double bond of the target compounds.
  Medline CASGoogle Scholar
• 15 Cabrera M, Gomez N, Remes Lenicov F et al. G2/M cell cycle arrest and tumor selective apoptosis of acute leukemia cells by a promising benzophenone thiosemicarbazone compound. PLoS ONE 10(9), e0136878 (2015).
  MedlineGoogle Scholar
• 16 Dagon Y, Dovrat S, Vilchik S et al. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells. Oncogene 20(56), 8045–8056 (20001).
  Google Scholar
• 17 García-Rubiño ME, Conejo-García A, Núñez MC et al. Enantiospecific synthesis of heterocycles linked to purines: different apoptosis modulation of enantiomers in breast cancer cells. Curr. Med. Chem. 20(38), 4924–4934 (2013).
  Medline CASGoogle Scholar
• 18 You BR, Park WH. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion. Oncol. Rep. 35(1), 546–551 (2016).
  Medline CASGoogle Scholar
• 19 Papanikolaou X, Johnson S, Garg T et al. Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget 5(12), 4118–4128 (2014). •• Interesting research article of a drug that exhibits a caspase-independent apoptosis as our structures.
  MedlineGoogle Scholar
• 20 Ishaq M, Ojha R, Sharma K, Sharma G, Singh SK, Majumdar S. Functional inhibition of Hsp70 by Pifithrin-μ switches Gambogic acid induced caspase dependent cell death to caspase independent cell death in human bladder cancer cells. Biochim. Biophys. Acta 1863(11), 2560–2573 (2016).
  Medline CASGoogle Scholar
• 21 Suparji NS, Chan G, Sapili H et al. Geranylated 4-phenylcoumarins exhibit anticancer effects against human prostate cancer cells through caspase-independent mechanism. PLoS ONE 11(3), e0151472 (2016).
  MedlineGoogle Scholar
• 22 Göke A, Göke R, Ofner A, Herbst A, Lankat-Buttgereit B. The FGFR inhibitor NVP-BGJ398 induces NSCLC cell death by activating caspase-dependent pathways as well as caspase-independent apoptosis. Anticancer Res. 35(11), 5873–5879 (2015).
  MedlineGoogle Scholar
• 23 Lopez-Cruzan M, Sharma R, Tiwari M, Karbach S, Holstein D, Martin CR, Lechleiter JD, Herman B. Caspase-2 resides in the mitochondria and mediates apoptosis directly from the mitochondrial compartment. Cell Death Discov. 2, 16005 (2016).
  Medline CASGoogle Scholar
• 24 Birge RB, Boeltz S, Kumar S et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 23(6), 962–78 (2016).
  Medline CASGoogle Scholar
• 25 Marchal JA, Lopez GJ, Peran M et al. The impact of PKR activation:from neurodegeneration to cancer. FASEB J. 28(5), 1965–1974 (2014).
  Medline CASGoogle Scholar